Is Altimmune, Inc. overvalued?

Altimmune, Inc. (ALT) — key valuation metrics and fundamentals.

No verdict

Price

$2.94

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$571.8M

Dividend yield

58200.3%

Return on equity

-42.6%

Sector

Healthcare

Fair value compares ALT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks